Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach

Curr Oncol. 2022 Apr 24;29(5):3026-3043. doi: 10.3390/curroncol29050246.

Abstract

Neoplasms with plasma cell differentiation may occasionally involve the skin. Cutaneous lesions may represent the first sign of an underlying systemic plasma cell malignancy, such as multiple myeloma, or the skin itself may be the primary site of occurrence of a hematological tumor with plasma cell differentiation. Starting from examples encountered in our daily practice, we discussed the diagnostic approach pathologists and clinicians should use when faced with cutaneous lesions with plasma cell differentiation. Cases of primary cutaneous marginal zone lymphoma, localized primary amyloidosis/amyloidoma, and cutaneous manifestations (secondary either to multiple myeloma or to plasmablastic lymphoma) are discussed, focusing on the importance of the adequate patient's work-up and precise clinicopathological correlation to get to the correct diagnosis and appropriate treatment. The pertinent literature has been reviewed, and the clinical presentation, pathological findings, main differential diagnoses, treatment, and outcome of neoplasms with plasma cell differentiation involving the skin are discussed.

Keywords: amyloidoma; multiple myeloma; plasma cell neoplasms; plasmablastic lymphoma; primary cutaneous marginal zone lymphoma.

MeSH terms

  • Cell Differentiation
  • Hematologic Neoplasms*
  • Humans
  • Multiple Myeloma* / complications
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology